Study of HeartLight during catheter ablation for irregular heartbeat

This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.

This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.

This study tracks results after a heart ablation procedure used to treat atrial fibrillation (an irregular heart rhythm). You may be asked to help by consenting and following the study plan so the researchers can better understand what happens after ablations.

This study tests a special catheter that uses two types of energy to fix the irregular heartbeats in people with persistent atrial fibrillation (AFib). It aims to see if it's safe and effective in helping restore a normal heart rhythm.

This trial studies a heart procedure using the Affera SpherePVI system to treat paroxysmal (comes and goes) or persistent atrial fibrillation. It’s for people who still have symptoms despite at least one anti-arrhythmia medicine, and who are good candidates for catheter ablation.

This trial tests a newer way to treat atrial fibrillation (an irregular heartbeat) in people who have already had a procedure to close off the left atrial appendage, a small pouch in the heart that can collect blood and cause strokes. The treatment uses pulsed field energy to target tissue causing the irregular rhythm, which may be safer than standard approaches.